KAY CHRISTINA 4
4 · INTEGRATED BIOPHARMA INC · Filed Dec 5, 2024
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Award
Stock Option (right to buy)
2024-12-04+125,000→ 125,000 totalExercise: $0.34Exp: 2034-12-04→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025.